4.2200
0.0000
(0.00%)
As of January 30 at 3:00:00 PM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-62,041.0000
-59,005.0000
118,566.0000
-90,953.0000
-28,983.0000
Investing Cash Flow
64,438.0000
44,637.0000
-101,121.0000
-22,237.0000
-21,746.0000
Financing Cash Flow
-1,166.0000
-1,167.0000
-1,570.0000
50,581.0000
113,202.0000
End Cash Position
69,630.0000
67,309.0000
87,946.0000
71,813.0000
133,721.0000
Capital Expenditure
-896.0000
-808.0000
-1,417.0000
-1,307.0000
-1,683.0000
Issuance of Capital Stock
--
--
--
51,493.0000
113,613.0000
Repayment of Debt
-1,205.0000
-1,198.0000
-1,189.0000
-1,179.0000
-1,251.0000
Repurchase of Capital Stock
--
--
-631.0000
--
--
Free Cash Flow
-62,937.0000
-59,813.0000
117,149.0000
-92,260.0000
-30,666.0000
12/31/2020 - 6/14/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BOVNF BioInvent International AB (publ)
4.7000
0.00%
SNBIF SanBio Company Limited
4.6500
0.00%
HNSBF Hansa Biopharma AB (publ)
3.0000
0.00%
GNNSF Genscript Biotech Corporation
1.3550
0.00%
ASCLF Ascletis Pharma Inc.
0.2393
0.00%
PBIGF Paradigm Biopharmaceuticals Limited
0.3280
0.00%
OXBDF Oxford Biomedica plc
5.56
0.00%
VBIZF Viva Biotech Holdings
0.0950
0.00%
TRGNF Transgene SA
1.5900
0.00%
IPHYF Innate Pharma S.A.
2.9000
0.00%